BLLN Latest Press Releases

-- October 27, 2026 --

BillionToOne to Participate in Two Upcoming Investor Conferences Globe Newswire 8:05 AM

-- October 14, 2026 --

BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026 Globe Newswire 8:05 AM

-- October 7, 2026 --

BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds Globe Newswire 7:00 AM

-- September 2, 2026 --

BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference PRNewswire 4:06 PM

-- September 1, 2026 --

BillionToOne Launches Northstar Origin, a New Liquid Biopsy Test to Help Identify Tissue of Origin PRNewswire 9:01 AM

-- August 19, 2026 --

/C O R R E C T I O N -- BillionToOne/ PRNewswire 10:22 AM

-- August 18, 2026 --

Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions PRNewswire 12:09 PM

-- August 5, 2026 --

BillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance Globe Newswire 4:05 PM

-- July 20, 2026 --

BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar PRNewswire 9:00 AM

-- July 15, 2026 --

BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026 Globe Newswire 8:05 AM

-- June 29, 2026 --

BillionToOne's Northstar Response Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-of-Care Imaging for Cancer Patients in Peer-Reviewed Study PRNewswire 12:40 PM

Market Data Delayed 15 Minutes